Press Releases

 
Press Releases
  Date Title View
Sep 7, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, will present in a fireside chat format discussion at the Morgan Stanley 15th Annual Global Healthcare Conference at the Grand Hyatt Hotel in New York, NY, ...
Aug 30, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer and Eric d'Esparbes, the Company's Senior Vice President and Chief Financial Officer will participate in the 2017 Baird Global Healthcare Conference a...
Aug 21, 2017
Closes $250 Million Term B Loan Refinancing plan expected to reduce the associated current cash interest expense by nearly one-half BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. ("Innoviva" or the "Company") (NASDAQ: INVA) today announced the closing of a $250 m...
Aug 7, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) (the "Company" or "Innoviva") today announced that it closed its offering of the Company's 2.50% convertible senior notes due 2025 (the "Notes") for gross proceeds of $192.5 million in aggregate principal. The proceeds include the Notes sold pursua...
Aug 1, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) (the "Company" or "Innoviva") today announced the pricing of $175 million aggregate principal amount of the Company's 2.50% convertible senior notes due 2025 (the "Notes"). The Notes will be sold in a private placement to qualified institutional ...
Jul 31, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) (the "Company" or "Innoviva") today announced its intention to offer, subject to market conditions and other factors, $175 million aggregate principal amount of convertible senior notes due 2025 (the "Notes") in a private placement to qualified ...
Jul 26, 2017
Royalties earned up 73% and net income up 141% compared to second quarter of 2016 Management to host a conference call and webcast today at 5:00 p.m. Eastern time BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) (the Company) toda...
Jul 21, 2017
LONDON--(BUSINESS WIRE)-- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submission to the European Medicines Agency (EMA) for the extended use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI), an inhaled corticosteroid (ICS) / long-acting ^...
Jul 19, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the second quarter ended June 30, 2017 after market close on Wednesday, July 26, 2017. Following the earnings release, Innoviva management will host a webcast and conference call at ...
May 10, 2017
BRISBANE, Calif.--(BUSINESS WIRE)-- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, and Eric d'Esparbes, the Company's Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the Bank of America Merr...
FirstPrevious
2
...
NextLast
= add release to Briefcase

Innoviva NASDAQ: INVA

$13.06 0.09 (0.69%) 11/17/17 4:00 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.